🇺🇸 FDA
Pipeline program

IAE0972+ Methotrexate

IAE0972-201

Phase 3 mab active

Quick answer

IAE0972+ Methotrexate for NPC is a Phase 3 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
NPC
Phase
Phase 3
Modality
mab
Status
active

Clinical trials